Cargando…
Harnessing the protective potential of HIV-1 neutralizing antibodies
Recent biological, structural, and technical advances are converging within the HIV-1 vaccine field to harness the power of antibodies for prevention and therapy. Numerous monoclonal antibodies with broad neutralizing activity against diverse HIV-1 isolates have now been identified, revealing at lea...
Autores principales: | Smith, S Abigail, Derdeyn, Cynthia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754033/ https://www.ncbi.nlm.nih.gov/pubmed/26918160 http://dx.doi.org/10.12688/f1000research.7254.1 |
Ejemplares similares
-
VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120
por: Smith, S. Abigail, et al.
Publicado: (2019) -
Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth
por: Murphy, Megan K., et al.
Publicado: (2013) -
Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
por: Archary, D, et al.
Publicado: (2012) -
Neutralizing antibodies to HIV-1 induced by immunization
por: McCoy, Laura E., et al.
Publicado: (2013) -
Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
por: Smith, S. Abigail, et al.
Publicado: (2016)